Top of this page
Skip navigation, go straight to the content

Our Products Products Neupro® - Restless legs syndrome

Neupro® - Restless Legs Syndrome

 
image description
 

Europe

In Europe, Neupro® is indicated for the symptomatic treatment of moderate to severe idiopathic Restless Legs Syndrome in adults.

USA

In the US, Neupro® (Rotigotine Transdermal System) is indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome.

Other countries

For availability of Neupro® in other countries, please consult our local websites.